Business News Distributed by GlobeNewswire
Firm launches two new ETFs to diversify product offering for investorsCINCINNATI, July 30, 2024 (GLOBE …
Category:
GlobeNewswire
-
-
NEW YORK, NY, July 29, 2024 (GLOBE NEWSWIRE) — FindRemoteJobs is proud to announce the …
-
BusinessGlobeNewswire
United States K-12 Reading Report 2024: Literacy Gaps, Changes in State Policies and Trends Impacting Reading Instruction
Dublin, July 29, 2024 (GLOBE NEWSWIRE) — The “K-12 Reading Market Report, 2024” has been …
-
BusinessGlobeNewswire
Acumen Pharmaceuticals Presents Patient Experience and Biomarker Data from Phase 1 INTERCEPT-AD Study at the Alzheimer’s Association International Conference (AAIC®) 2024
NEWTON, Mass., July 28, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage …
-
BusinessGlobeNewswire
Global Kosher Food Market Size To Worth USD 73.51 Billion By 2033 l CAGR Of 6.11%
The Global Kosher Food Market Size was Valued at USD 40.61 Billion in 2023 and …
-
BusinessGlobeNewswire
BALY INVESTIGATION: The M&A Class Action Firm Launches Investigation Merger of Bally’s Corp.
NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) — NEW YORK, July 27, 2024 / GlobeNewswire/– …
-
BusinessGlobeNewswire
COFS ALERT: The M&A Class Action Firm Launches Investigation of the Merger of ChoiceOne Financial Services, Inc.
NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) — NEW YORK, July 26, 2024 Monteverde & …
-
Real-World Assets and institutional trading platform tanX has processed 11m transactions and over $2B in …
-
BusinessGlobeNewswire
Secure, Fair, and Quantum-Driven: The Qrng Randomizer Blockchain by Qrng Solutions Ltd
The Sp8de project is an open-source network providing decentralized, verifiable quantum randomness as a service.London, …
-
BusinessGlobeNewswire
Hepatitis A Therapeutics Market Research 2024: Comprehensive Insights about 3+ Companies and 3+ Pipeline Drugs Featuring Boryung Pharma, Cadila Healthcare, Indian Immunologicals, & Biological E
Dublin, July 25, 2024 (GLOBE NEWSWIRE) — The “Hepatitis A – Pipeline Insight, 2024” clinical …